Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Activated T Cells After PBSCT in Stage IV Breast Cancer
NCT00020722Phase 2Terminated
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Start
- Aug 2007
- Primary completion
- Mar 2013
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of therapeutic autologous lymphocytes in breast cancer, sponsored by Barbara Ann Karmanos Cancer Institute. Started Aug 2007; status: terminated.
02
Drugs
therapeutic autologous lymphocytes
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00020722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00020722.